United Therapeutics
UTHR
UTHR
459 hedge funds and large institutions have $9.42B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 169 increasing their positions, 160 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $10.3B → $9.42B (-$879M)
11% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 61
25% less funds holding in top 10
Funds holding in top 10: 24 → 18 (-6)
Holders
459
Holding in Top 10
18
Calls
$104M
Puts
$51M
Top Buyers
| 1 | +$197M | |
| 2 | +$116M | |
| 3 | +$59.6M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$51.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.2M |
Top Sellers
| 1 | -$51M | |
| 2 | -$39.1M | |
| 3 | -$36.5M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$33.8M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$33.2M |